Significant Improvement in Survival after Unrelated Donor Hematopoietic Cell Transplantation in the Recent Era

Navneet S. Majhail, Pintip Chitphakdithai, Brent Logan, Roberta King, Steven Devine, Susan N. Rossmann, Gregory Hale, Robert J. Hartzman, Chatchada Karanes, Ginna G. Laport, Eneida Nemecek, Edward L. Snyder, Galen E. Switzer, John Miller, Willis Navarro, Dennis L. Confer, John E. Levine

Research output: Contribution to journal › Article

34 Citations (Scopus)

Abstract

Patients and physicians may defer unrelated donor hematopoietic cell transplantation (HCT) as curative therapy because of the mortality risk associated with the procedure. Therefore, it is important for physicians to know the current outcomes data when counseling potential candidates. To provide this information, we evaluated 15,059 unrelated donor hematopoietic cell transplant recipients between 2000 and 2009. We compared outcomes before and after 2005 for 4 cohorts: age

Original languageEnglish (US)
Pages (from-to)142-150
Number of pages9
JournalBiology of Blood and Marrow Transplantation
Volume21
Issue number1
DOIs
StatePublished - Jan 1 2015

Fingerprint

Unrelated Donors
Cell Transplantation
Physicians
Survival
Counseling
Transplants
Mortality
Therapeutics
Transplant Recipients

Keywords

  • Hematopoietic cell transplantation
  • National Marrow Donor Program
  • Survival
  • Treatment-related mortality
  • Unrelated donors

ASJC Scopus subject areas

  • Transplantation
  • Hematology

Cite this

Majhail, N. S., Chitphakdithai, P., Logan, B., King, R., Devine, S., Rossmann, S. N., ... Levine, J. E. (2015). Significant Improvement in Survival after Unrelated Donor Hematopoietic Cell Transplantation in the Recent Era. Biology of Blood and Marrow Transplantation, 21(1), 142-150. https://doi.org/10.1016/j.bbmt.2014.10.001

Significant Improvement in Survival after Unrelated Donor Hematopoietic Cell Transplantation in the Recent Era. / Majhail, Navneet S.; Chitphakdithai, Pintip; Logan, Brent; King, Roberta; Devine, Steven; Rossmann, Susan N.; Hale, Gregory; Hartzman, Robert J.; Karanes, Chatchada; Laport, Ginna G.; Nemecek, Eneida; Snyder, Edward L.; Switzer, Galen E.; Miller, John; Navarro, Willis; Confer, Dennis L.; Levine, John E.

In: Biology of Blood and Marrow Transplantation, Vol. 21, No. 1, 01.01.2015, p. 142-150.

Research output: Contribution to journal › Article

Majhail, NS, Chitphakdithai, P, Logan, B, King, R, Devine, S, Rossmann, SN, Hale, G, Hartzman, RJ, Karanes, C, Laport, GG, Nemecek, E, Snyder, EL, Switzer, GE, Miller, J, Navarro, W, Confer, DL & Levine, JE 2015, 'Significant Improvement in Survival after Unrelated Donor Hematopoietic Cell Transplantation in the Recent Era', Biology of Blood and Marrow Transplantation, vol. 21, no. 1, pp. 142-150. https://doi.org/10.1016/j.bbmt.2014.10.001
Majhail NS, Chitphakdithai P, Logan B, King R, Devine S, Rossmann SN et al. Significant Improvement in Survival after Unrelated Donor Hematopoietic Cell Transplantation in the Recent Era. Biology of Blood and Marrow Transplantation. 2015 Jan 1;21(1):142-150. https://doi.org/10.1016/j.bbmt.2014.10.001
Majhail, Navneet S. ; Chitphakdithai, Pintip ; Logan, Brent ; King, Roberta ; Devine, Steven ; Rossmann, Susan N. ; Hale, Gregory ; Hartzman, Robert J. ; Karanes, Chatchada ; Laport, Ginna G. ; Nemecek, Eneida ; Snyder, Edward L. ; Switzer, Galen E. ; Miller, John ; Navarro, Willis ; Confer, Dennis L. ; Levine, John E. / Significant Improvement in Survival after Unrelated Donor Hematopoietic Cell Transplantation in the Recent Era. In: Biology of Blood and Marrow Transplantation. 2015 ; Vol. 21, No. 1. pp. 142-150.
@article{fe580f79b2df42c8b159a271d8740a9a,
title = "Significant Improvement in Survival after Unrelated Donor Hematopoietic Cell Transplantation in the Recent Era",
abstract = "Patients and physicians may defer unrelated donor hematopoietic cell transplantation (HCT) as curative therapy because of the mortality risk associated with the procedure. Therefore, it is important for physicians to know the current outcomes data when counseling potential candidates. To provide this information, we evaluated 15,059 unrelated donor hematopoietic cell transplant recipients between 2000 and 2009. We compared outcomes before and after 2005 for 4 cohorts: age",
keywords = "Hematopoietic cell transplantation, National Marrow Donor Program, Survival, Treatment-related mortality, Unrelated donors",
author = "Majhail, {Navneet S.} and Pintip Chitphakdithai and Brent Logan and Roberta King and Steven Devine and Rossmann, {Susan N.} and Gregory Hale and Hartzman, {Robert J.} and Chatchada Karanes and Laport, {Ginna G.} and Eneida Nemecek and Snyder, {Edward L.} and Switzer, {Galen E.} and John Miller and Willis Navarro and Confer, {Dennis L.} and Levine, {John E.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/j.bbmt.2014.10.001",
language = "English (US)",
volume = "21",
pages = "142--150",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Significant Improvement in Survival after Unrelated Donor Hematopoietic Cell Transplantation in the Recent Era

AU - Majhail, Navneet S.

AU - Chitphakdithai, Pintip

AU - Logan, Brent

AU - King, Roberta

AU - Devine, Steven

AU - Rossmann, Susan N.

AU - Hale, Gregory

AU - Hartzman, Robert J.

AU - Karanes, Chatchada

AU - Laport, Ginna G.

AU - Nemecek, Eneida

AU - Snyder, Edward L.

AU - Switzer, Galen E.

AU - Miller, John

AU - Navarro, Willis

AU - Confer, Dennis L.

AU - Levine, John E.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Patients and physicians may defer unrelated donor hematopoietic cell transplantation (HCT) as curative therapy because of the mortality risk associated with the procedure. Therefore, it is important for physicians to know the current outcomes data when counseling potential candidates. To provide this information, we evaluated 15,059 unrelated donor hematopoietic cell transplant recipients between 2000 and 2009. We compared outcomes before and after 2005 for 4 cohorts: age

AB - Patients and physicians may defer unrelated donor hematopoietic cell transplantation (HCT) as curative therapy because of the mortality risk associated with the procedure. Therefore, it is important for physicians to know the current outcomes data when counseling potential candidates. To provide this information, we evaluated 15,059 unrelated donor hematopoietic cell transplant recipients between 2000 and 2009. We compared outcomes before and after 2005 for 4 cohorts: age

KW - Hematopoietic cell transplantation

KW - National Marrow Donor Program

KW - Survival

KW - Treatment-related mortality

KW - Unrelated donors

UR - http://www.scopus.com/inward/record.url?scp=84927152756&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927152756&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2014.10.001

DO - 10.1016/j.bbmt.2014.10.001

M3 - Article

C2 - 25445638

AN - SCOPUS:84927152756

VL - 21

SP - 142

EP - 150

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 1

ER -

Access to Document